Royal Bank of Canada
VAXX

Royal Bank of Canada’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Royal Bank of Canada’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-974
Closed -$1K – 7759
2024
Q1 		$1K Sell
974
-12,784
-93% -$9.27K ﹤0.01% 6923
2023
Q4 		$12K Buy
13,758
+5,970
+77% +$5.76K ﹤0.01% 6465
2023
Q3 		$10K Buy
7,788
+2,140
+38% +$4.64K ﹤0.01% 6431
2023
Q2 		$15K Buy
5,648
+5,441
+2,629% +$11.5K ﹤0.01% 6341
2023
Q1 		$0 Buy
+207
New +$525 ﹤0.01% 7638
2022
Q3 		– Sell
-1,000
Closed -$2K – 8030
2022
Q2 		$2K Buy
+1,000
New +$3.78K ﹤0.01% 7025

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Royal Bank of Canada's VAXX Position: Q2 2024 in Review

Royal Bank of Canada sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 974 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in VAXX in Q2 2022 and held it in 6 quarters. The position peaked at $15K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Royal Bank of Canada reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 974 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $1K.
  • Royal Bank of Canada first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 6 quarters.
  • Royal Bank of Canada's Vaxxinity, Inc. Class A Common Stock position peaked at $15K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.